Bcl10 aberations and nf-kappa b activation involving p65 are absent or rare in primary gastric MALT lymphoma;Bcl10 aberacije i aktivacija p65 gena nf-kappa b puta su odsutne ili retke u primarnom MALT limfomu želuca

Vojnosanitetski Pregled

Volumn 71, Issue 11, 2014, Pages 1040-1044

  Hajder, Jelena ^a   Marisavljević, Dragomir ^b   Stanisavljević, Natasa ^a   Mihaljević, Biljana ^c   Kovčin, Vladimir ^a   Marković, Olivera ^a   Živković, Radmila ^d  

^a Clinical Hospital Center Be anijska kosa   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c CLINICAL CENTER OF SERBIA   (Serbia)

^d Clinic for Hematology   (Serbia)

Author keywords

B cell; Gene expression; Immunohistochemistry; Lymphoma; Marginal zone; Signal transduction; Stomach neoplasms

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BCL 10; BCL10 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TUMOR MARKER;

ADULT; ARTICLE; CANCER REGRESSION; CARCINOGENESIS; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; HELICOBACTER INFECTION; HUMAN; MALE; MARGINAL ZONE LYMPHOMA; MEDICAL RECORD; MIDDLE AGED; PROTEIN EXPRESSION; WEIGHT REDUCTION; AGED; BIOPSY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; IMMUNOHISTOCHEMISTRY; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; STOMACH TUMOR;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; BIOPSY; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, B-CELL, MARGINAL ZONE; MALE; MIDDLE AGED; NF-KAPPA B; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84919825930     PISSN: 00428450     EISSN: None     Source Type: Journal    
DOI: 10.2298/VSP130813035H     Document Type: Article

References (23)

1. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17(12): 3835-49.
2. Thieblemont C. Clinical presentation and management of marginal zone lymphomas. Hematology Am Soc Hematol Educ Program 2005: 307-13.
3. Ferrucci PF, Zucca E. Primary gastric lymphoma pathogenesis and treatment: what has changed over the past 10 years. Br J Haematol 2007; 136(4): 521-38.
4. Pozzi B, Cerati M, Capella C. MALT lymphoma: pathology. In: Bertoni F, Zucca E editor. MALT lymphomas. Georgetown (TX): Landes Bioscience/Kluwer Plenum Publishers; 2004. p. 17-38.
5. Thieblemont C, Coffier B. MALT lymphomas. Sites of Presentations, Clinical features and Staging Procedures. In: Bertoni F, Zucca E editor. MALT lymphomas. Georgetown (TX): Landes Bioscience/Kluwer Plenum Publishers; 2004. p. 60-80.
6. Katič V, Katič K, Vučetič M, Gligorijevič J. The histopathology and immunohistology of gastric MALT lymphoma. Arch Oncol 2004; 12(1): 5-6.
7. Kahl BS. Update: gastric MAcLT lymphoma. Curr Opin Oncol 2003; 15: 347-52.
8. Nakagawa M, Hosokawa Y, Yonezumi M, Izumiyama K, Suzuki R, Tsuzuki S, et al. MALT1 contains nuclear export signals and regulates cytoplasmic localization of BCL10. Blood 2005; 106(13): 4210-6.
9. Hachem A, Gartenhaus RB. Oncogenes as molecular targets in lymphoma. Blood 2005; 106(6): 1911-23.
10. Bugarski D, Petakov M, Vlaski M, Krstič A, Čokič V, Jovčič G, et al. Mehanizmi prenosa signala u toku stimulacije matičnih čelija hematopoeze. Bilten za hematologiju 2004; 32(3): 156-9. (Serbian)
11. Lucas PC, Yonezumi M, Inohara N, Mcallister-Lucas LM, Abazeed ME, Chen FF, et al. Bcl10 and MALT1, Independent Targets of Chromosomal Translocation in MALT Lymphoma, Cooperate in a Novel NF-kappa B Signaling Pathway. J Biol Chem 2001; 276(22): 19012-9.
12. Isaacson PG, Du M. MALT lymphoma: from morphology to molecules. Nat Rev Cancer 2004; 4(8): 644-53.
13. Ye H, Gong L, Liu H, Hamoudi RA, Shirali S, Ho L, et al. MALT lymphoma with t(14;18)(q32;q21)/IGH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression. J Pathol 2005; 205(3): 293-301.
14. Bertoni F, Cotter F. MALT lymphomas. Genetics and Biology. In: Bertoni F, Zucca E editor. MALT lymphomas. Georgetown (TX): Landes Bioscience/Kluwer Plenum Publishers; 2004. p. 46-59.
15. Ye H, Dogan A, Karran L, Willis TG, Chen L, Wlodarska I, et al. BCL10 Expression in Normal and Neoplastic Lymphoid Tissue: Nuclear localisation in MALT lymphoma. Am J Pathol 2000; 157(4): 1147-54.
16. Cavalli F, Isaacson PG, Gascoyne RD, Zucca E. MALT Lymphomas. Hematology Am Soc Hematol Educ Program 2001: 241-58.
17. Lui H, Ye H, Dogan A, Ranaldi R, Hamoudi RA, Bearzi I, et al. T(11;18)(q21;q21) is associated with advanced mucosaassociated lymphoid tissue lymphoma that expresses nuclear BCL10. Blood 2001; 98(4): 1182-7.
18. Yeh KH, Kuo SH, Chen LT, Mao TL, Doong SL, Wu MS, et al. Nuclear expression of BCL10 or nuclear factor kappa B helps predict Helicobacter pylori-independent status of low-grade gastric mucosa-associated lymphoid tissue lymphomas with or without t(11;18)(q21;q21). Blood 2005; 106(3): 1037-41.
19. Franco R, Camacho FI, Caleo A, Staibano S, Bifano D, de Renzo A, et al. Nuclear bcl10 expression characterizes a group of ocular adnexa MALT lymphomas with shorter failure-free survival. Mod Pathol 2006; 19(8): 1055-67.
20. Gilmore TD, Kalaitzidis D, Liang MC, Starczynowski DT. The c-Rel transcription factor and B-cell proliferation: a deal with the devil. Oncogene 2004; 23(13): 2275-86.
21. Talwalkar SS, Valbuena JR, Abruzzo LV, Admirand JH, Konoplev SN, Bueso-Ramos CE, et al. MALT1 gene rerrangements and NF-kappaB activation involving p65 and p50 are absent or rare in primary MALT lymphomas of the breast. Mod Pathol 2006; 19(11): 1402-8.
22. Sagaert X, Laurent M, Baens M, Wlodarska I, de Wolf-Peeters C. MALT1 and BCL10 aberrations in MALT lymphomas and their effect on the expression of BCL10 in the tumour cells. Mod Pathol 2006; 19(2): 225-32.
23. Sagaert X, de Wolf-Peeters C, Noels H, Baens M. The pathogenesis of MALT lymphomas: where do we stand. Leukemia 2007; 21(3): 389-96.